The efficacy of oral non-steroidal anti-inflammatory drugs for rotator cuff tendinopathy: A systematic review and meta-analysis

Journal of Rehabilitation Medicine

Volumn 46, Issue 4, 2014, Pages 294-306

  Boudreault, Jennifer ^a   Desmeules, François ^a,b   Roy, Jean Sébastien ^c,d   Dionne, Clermont ^c,e   Frémont, Pierre ^c,e   MacDermid, Joy C ^f  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d CENTER FOR INTERDISCIPLINARY RESEARCH IN REHABILITATION AND SOCIAL INTEGRATION   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Anti inflammatory agents; Rotator cuff; Shoulder; Tendinopathy

Indexed keywords

CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DOSE RESPONSE; HUMAN; INJECTION; META ANALYSIS; REVIEW; ROTATOR CUFF; SHOULDER PAIN; TENDINITIS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS; ROTATOR CUFF; SHOULDER PAIN; TENDINOPATHY; TREATMENT OUTCOME;

EID: 84908491656     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-1800     Document Type: Review

References (48)

1. Tekavec E, Joud A, Rittner R, Mikoczy Z, Nordander C, Petersson IF, et al. Population-based consultation patterns in patients with shoulder pain diagnoses. BMC Musculoskelet Disord 2012; 13: 238.
2. Lewis JS. Rotator cuff tendinopathy. Br J Sports Medicine 2009; 43: 236-241.
3. Hanratty CE, McVeigh JG, Kerr DP, Basford JR, Finch MB, Pendleton A, et al. The effectiveness of physiotherapy exercises in subacromial impingement syndrome: a systematic review and meta-analysis. Semin Arthritis Rheum 2012; 42: 297-316.
4. Seitz AL, McClure PW, Finucane S, Boardman ND 3rd, Michener LA. Mechanisms of rotator cuff tendinopathy: intrinsic, extrinsic, or both? Clin Biomech (Bristol, Avon) 2011; 26: 1-12.
5. Neer CS, 2nd. Anterior acromioplasty for the chronic impingement syndrome in the shoulder: a preliminary report. J Bone Joint Surg Am 1972; 54: 41-50.
6. Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res 2008; 466: 1539-1554.
7. Orchard J, Kountouris A. The management of tennis elbow. BMJ 2011; 342: d2687.
8. Skjong CC, Meininger AK, Ho SS. Tendinopathy treatment: where is the evidence? Clin Sports Med 2012; 31: 329-350.
9. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a Scientific statement from the American Heart Association. Circulation 2007; 115: 1634-1642.
10. Hawkey CJ, Langman MJ. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 2003; 52: 600-608.
11. Roubille C, Martel-Pelletier J, Davy JM, Haraoui B, Pelletier JP. Cardiovascular adverse effects of anti-inflammatory drugs. Anti-inflamm Antiallergy Agents Med Chem 2013; 12: 55-67.
12. Paoloni JA, Milne C, Orchard J, Hamilton B. Non-steroidal anti-inflammatory drugs in sports medicine: guidelines for practical but sensible use. Br J Sports Med 2009; 43: 863-865.
13. Alfredson H, Lorentzon R. Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment? Current drug targets 2002; 3: 43-54.
14. Fredberg U, Stengaard-Pedersen K. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports 2008; 18: 3-15.
15. Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 1999; 27: 393-408.
16. Maffulli N, Sharma P, Luscombe KL. Achilles tendinopathy: aetiology and management. J R Soc Med 2004; 97: 472-476.
17. Ziltener JL, Leal S, Fournier PE. Non-steroidal anti-inflammatory drugs for athletes: an update. Ann Phys Rehabil Med 2010; 53: 278-282, 282-288.
18. Millar NL, Hueber AJ, Reilly JH, Xu Y, Fazzi UG, Murrell GA, et al. Inflammation is present in early human tendinopathy. The Am J Sports Med 2010; 38: 2085-2091.
19. Green S, Buchbinder R, Glazier R, Forbes A. Systematic review of randomised controlled trials of interventions for painful shoulder: selection criteria, outcome assessment, and efficacy. BMJ 1998; 316: 354-360.
20. van der Windt DA, van der Heijden GJ, Scholten RJ, Koes BW, Bouter LM. The efficacy of non-steroidal anti-inflammatory drugs (NSAIDS) for shoulder complaints. A systematic review. J Clin Epidemiol 1995; 48: 691-704.
21. van der Sande R, Rinkel WD, Gebremariam L, Hay EM, Koes BW, Huisstede BM. Subacromial impingement syndrome: effectiveness of pharmaceutical interventions-nonsteroidal anti-inflammatory drugs, corticosteroid, or other injections: a systematic review. Arch Phys Med Rehabil 2013; 94: 961-976.
22. Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Greens S, editors. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2008. Available from: http://www.cochrane.org/sites/default/files/uploads/handbook/Handbook510pdf-Ch08-RiskOfBias.pdf.
23. Higgins JPT, Green S, Collaboration C. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: Wiley-Blackwell; 2008.
24. Lopez JM. Treatment of acute tendinitis and bursitis with fentiazac - a double-blind comparison with placebo. Clin Ther 1982; 5: 79-84.
25. Wielandts L, Dequeker J. Double-blind trial comparing fentiazac with phenylbutazone in patients with tendinitis. Current Medical Research and Opinion 1979; 6: 85-89.
26. Dougados M, Henanff AL, Logeart I, Ravaud P. Short-Term Efficacy of Rofecoxib and diclofenac in acute shoulder pain: A placebo-controlled randomized trial. PLoS Clin Trials 2007; 2: e9.
27. Zuinen C. Diclofenac/misoprostol vs diclofenac/placebo in treating acute episodes of tendinitis/bursitis of the shoulder. Drugs 1993; 45 Suppl 1: 17-23.
28. Wober W. Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulide. Rheumatology (Oxford) 1999; 38 Suppl 1: 33-38.
29. Wober W, Rahlfs VW, Buchl N, Grassle A, Macciocchi A. Comparative efficacy and safety of the non-steroidal anti-inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis. Int J Clin Pract 1998; 52: 169-175.
30. Smith MD, Thomas D, McCredie M, Brooks PM. Piroxicam versus naproxen in the treatment of painful shoulder. Pharmatherapeutica 1986; 4: 585-589.
31. Mena HR, Lomen PL, Turner LF, Lamborn KR, Brinn EL. Treatment of acute shoulder syndrome with flurbiprofen. Am J Med 1986; 80: 141-144.
32. Bertin P, Behier JM, Noel E, Leroux JL. Celecoxib is as efficacious as naproxen in the management of acute shoulder pain. J Int Med Res 2003; 31: 102-112.
33. Petri M, Hufman SL, Waser G, Cui H, Snabes MC, Verburg KM. Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. J Rheumatol 2004; 31: 1614-1620.
34. Adebajo AO, Nash P, Hazleman BL. A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol 1990; 17: 1207-1210.
35. Petri M, Dobrow R, Neiman R, Whiting-O'Keefe Q, Seaman WE. Randomized, double-blind, placebo-controlled study of the treatment of the painful shoulder. Arthritis Rheum 1987; 30: 1040-1045.
36. White RH, Paull DM, Fleming KW. Rotator cuff tendinitis: comparison of subacromial injection of a long acting corticosteroid versus oral indomethacin therapy. J Rheumatol 1986; 13: 608-613.
37. Friis J, Jarner D, Toft B, Christensen K, Christophersen J, Ibfeldt HH, et al. Comparison of two ibuprofen formulations in the treatment of shoulder tendonitis. Clin Rheumatol 1992; 11: 105-108.
38. Ginsberg F, Famaey JP. A double-blind comparison of slow-release and standard tablet formulations of fentiazac in the treatment of patients with tendinitis and bursitis. Curr Med Res Opin 1985; 9: 442-448.
39. England S, Farrell AJ, Coppock JS, Struthers G, Bacon PA. Low power laser therapy of shoulder tendonitis. Scand J Rheumatol 1989; 18: 427-431.
40. Soubrier M, Rosenbaum D, Tatar Z, Lahaye C, Dubost JJ, Mathieu S. Vascular effects of nonsteroidal antiinflammatory drugs. Joint Bone Spine 2013; 80: 358-362.
41. Muir SW, Corea CL, Beaupre L. Evaluating change in clinical status: reliability and measures of agreement for the assessment of glenohumeral range of motion. NAJSPT 2010; 5: 98-110.
42. Kamath CC, Kremers HM, Vanness DJ, O'Fallon WM, Cabanela RL, Gabriel SE. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. Value Health 2003; 6: 144-157.
43. Butterfield TA, Best TM, Merrick MA. The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train 2006; 41: 457-465.
44. Cohen DB, Kawamura S, Ehteshami JR, Rodeo SA. Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing. Am J Sports Med 2006; 34: 362-369.
45. Ferry ST, Dahners LE, Afshari HM, Weinhold PS. The effects of common anti-inflammatory drugs on the healing rat patellar tendon. Am J Sports Med 2007; 35: 1326-1333.
46. Radi ZA. Pathophysiology of cyclooxygenase inhibition in animal models. Toxicol Pathol 2009; 37: 34-46.
47. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134: 657-662.
48. Simpson MR, Howard TM. Tendinopathies of the foot and ankle. Am Fam Physician 2009; 80: 1107-1114.